Product Program year 2021 Source: CMS Open Payments

Vidas 3

Device immunodiagnostic

PDI 3573026380175

Open in the dashboard

General payments

$43,580

31 payments

Research payments

$0

0 payments

Through program year 2021, $43,580 in general payments and $0 in research payments were reported against Vidas 3 (immunodiagnostic).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $43,580 31

Breakdown

Who paid General payments · program year 2021
  1. bioMerieux $43,580 31 payments
Top recipients General payments · program year 2021
  1. Daniel Feinstein Critical Care Medicine · Pinehurst, NC $22,283 51% · 7 payments
  2. V Reddy Thoracic Surgery (Cardiothoracic Vascular Surgery) · Nashville, TN $11,900 27% · 4 payments
  3. Rosemary She Anatomic Pathology & Clinical Pathology · Duarte, CA $4,065 9% · 3 payments
  4. David Gilbert Infectious Disease · Portland, OR $3,400 8% · 2 payments
  5. Alfred Lardizabal Pulmonary Disease · Newark, NJ $1,500 3% · 1 payment

The top 5 of 19 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Critical Care Medicine Internal Medicine $22,283 51% · 1 practitioner
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,900 27% · 1 practitioner
  3. Anatomic Pathology & Clinical Pathology Pathology $4,065 9% · 1 practitioner
  4. Infectious Disease Internal Medicine $3,400 8% · 1 practitioner
  5. Pulmonary Disease Internal Medicine $1,500 3% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. North Carolina $22,283 51% · 1 recipient
  2. Tennessee $11,900 27% · 1 recipient
  3. California $4,097 9% · 2 recipients
  4. Oregon $3,400 8% · 1 recipient
  5. New Jersey $1,532 4% · 2 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

31 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record